Q1 2026 marked a strategic shift toward property operations, with net sales up 252% year-over-year and major acquisitions completed or signed. Operating loss widened due to transaction and medtech costs, but equity ratio improved to 76.8%.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.